Jean Bennett
27Patents
4h-index
39Co-inventors
63Inventor score
Filing activity: Feb 2, 1989 → Jan 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5012815A | Dynamic spectral phonocardiograph | Human Necessities | 107 | Expired |
| US4967760A | Dynamic spectral phonocardiograph | Human Necessities | 88 | Expired |
| US9567376B2 | Enhanced AAV-mediated gene transfer for retinal therapies | Chemistry; Metallurgy | 42 | Active |
| US8147823B2 | Method of treating or retarding the development of blindness | Chemistry; Metallurgy | 12 | Active |
| US9249425B2 | Proviral plasmids and production of recombinant adeno-associated virus | Chemistry; Metallurgy | 4 | Active |
| US10155794B2 | Compositions and methods for treatment of disorders related to CEP290 | Chemistry; Metallurgy | 3 | Active |
| US10392622B2 | Compositions and methods for self-regulated inducible gene expression | Chemistry; Metallurgy | 3 | Active |
| US10266845B2 | Enhanced AAV-mediated gene transfer for retinal therapies | Chemistry; Metallurgy | 3 | Active |
| US10987433B2 | Compositions and methods for correction of heritable ocular disease | Chemistry; Metallurgy | 3 | Active |
| US9896665B2 | Proviral plasmids and production of recombinant adeno-associated virus | Chemistry; Metallurgy | 1 | Active |
| US10668129B2 | Synergistic combination of neuronal viability factors and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10301366B2 | Compositions and methods for treatment of disorders related to CEP290 | Chemistry; Metallurgy | 1 | Active |
| US11197936B2 | Methods and compositions for treatment of disorders and diseases involving RDH12 | Chemistry; Metallurgy | 1 | Active |
| US11793887B2 | Gene therapy for treating peroxisomal disorders | Chemistry; Metallurgy | 0 | Active |
| US11090392B2 | Gene therapy for ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US11206977B2 | Vision test for determining retinal disease progression | Human Necessities | 0 | Active |
| US11993776B2 | Trans-splicing molecules | Chemistry; Metallurgy | 0 | Active |
| US9433688B2 | Method of treating or retarding the development of blindness | Chemistry; Metallurgy | 0 | Active |
| US10448823B2 | Apparatus and methods for testing visual function and functional vision at varying luminance levels | Human Necessities | 0 | Active |
| US10857240B2 | Methods and compositions for treatment of ocular disorders and blinding diseases | Chemistry; Metallurgy | 0 | Active |
| US11827898B2 | Gene therapy for ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US12419973B2 | Methods and compositions for treatment of disorders and diseases involving RDH12 | Chemistry; Metallurgy | 0 | Active |
| US10696983B2 | Method for transducing cells with primary cilia | Chemistry; Metallurgy | 0 | Active |
| US12403204B2 | Gene therapy for ocular disorders | Chemistry; Metallurgy | 0 | Active |
| US11879133B2 | Gene therapy for ocular disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.